Stay updated on Danirixin Safety & Efficacy in Adult Influenza Clinical Trial
Sign up to get notified when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.

Latest updates to the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe Locations section was updated with new regional entries (USA and Australia) and old location blocks removed, in Revision: v3.3.3.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision number changed from v3.2.0 to v3.3.2 on the page. This appears to be a minor site maintenance update rather than a modification to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedRemoved the funding-status notice from the page. The study details and related information remain unchanged.SummaryDifference0.3%

- Check61 days agoChange DetectedNo additions or deletions affecting core study information were detected; the page's content appears unchanged.SummaryDifference0.3%

- Check90 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference1%

- Check97 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, indicating a version bump with no other content changes.SummaryDifference0.0%

Stay in the know with updates to Danirixin Safety & Efficacy in Adult Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.